Esperion

[anonymous]

Yep another bad quarterly report. The hits just keep coming with Esperion. Missed their estimates again. More losses as they just keep adding up. Lawsuit not going well despite the legal firm they hired. Nothing has gone right since the start.

 

[anonymous]

We’re pretty excited to be joining on with the well vetted team at ESPR. Obviously with COVID it’s been a -frenetic launch environment but now it’s time to shine. The docs seem Uber excited about the drug and outcomes, fresh blood should help.elevate this to its rightful potential and place in the cardiovascular armamentarium… first second is a powerful space to be in given the large unmet need! Let’s go!

 

[anonymous]

Still blaming covid 3 years later!!The sales people are all underperformers with sketchy backgrounds. Another nice try asshole!

 

[anonymous]

Absolutely stunning that investment firms still hold shares of this dog. There sure are some dumbfucks on Wall St.

 

[anonymous]

We’re pretty excited to be joining on with the well vetted team at ESPR. Obviously with COVID it’s been a -frenetic launch environment but now it’s time to shine. The docs seem Uber excited about the drug and outcomes, fresh blood should help.elevate this to its rightful potential and place in the cardiovascular armamentarium… first second is a powerful space to be in given the large unmet need! Let’s go!

COVID excuse again ! - Pathetic

Docs seem " Uber " excited ? - You sir, will soon be employed as a Uber driver. Sorry that you went through the Scientific Hiring Process.

Fresh blood should help elevate ? - Wasn't the Scientific Hiring Process a success ? Are you donating at the Red Cross ?

Sunshine...you are living in a Fantasy world.

 

[anonymous]

COVID excuse again ! - Pathetic

Docs seem " Uber " excited ? - You sir, will soon be employed as a Uber driver. Sorry that you went through the Scientific Hiring Process.

Fresh blood should help elevate ? - Wasn't the Scientific Hiring Process a success ? Are you donating at the Red Cross ?

Sunshine...you are living in a Fantasy world.

As a relative newcomer, I’ve got to say that I’m pretty excited about the opportunity here. Some people have a hard time understanding the place and the role and positioning of the product, let’s be honest it’s not a Crestor. This can still be a blockbuster product without being first line. There are so many patients who are not at LDL goal in and who either cannot, or will not take a statin. Needles are not a great alternative. Insurance is also a big hurdle for these, so I’m figuring we can probably be at $1 billion a year in sales by 2025.

 

[anonymous]

As a relative newcomer, I’ve got to say that I’m pretty excited about the opportunity here. Some people have a hard time understanding the place and the role and positioning of the product, let’s be honest it’s not a Crestor. This can still be a blockbuster product without being first line. There are so many patients who are not at LDL goal in and who either cannot, or will not take a statin. Needles are not a great alternative. Insurance is also a big hurdle for these, so I’m figuring we can probably be at $1 billion a year in sales by 2025.

The culture was set during the scam interview process.
-Karen

 

[anonymous]

As a relative newcomer, I’ve got to say that I’m pretty excited about the opportunity here. Some people have a hard time understanding the place and the role and positioning of the product, let’s be honest it’s not a Crestor. This can still be a blockbuster product without being first line. There are so many patients who are not at LDL goal in and who either cannot, or will not take a statin. Needles are not a great alternative. Insurance is also a big hurdle for these, so I’m figuring we can probably be at $1 billion a year in sales by 2025.

Take another hit on the bong dipshit. This is a fantasy land post. Billions???? This had been a huge failure to date. Keep dreaming loser.

 

[anonymous]

Take another hit on the bong dipshit. This is a fantasy land post. Billions???? This had been a huge failure to date. Keep dreaming loser.

No need to be rude, Karen Balboa.

 

[anonymous]

As a relative newcomer, I’ve got to say that I’m pretty excited about the opportunity here. Some people have a hard time understanding the place and the role and positioning of the product, let’s be honest it’s not a Crestor. This can still be a blockbuster product without being first line. There are so many patients who are not at LDL goal in and who either cannot, or will not take a statin. Needles are not a great alternative. Insurance is also a big hurdle for these, so I’m figuring we can probably be at $1 billion a year in sales by 2025.

I advise you to do your research on statins. They are not needed. Search for the real information, not the Pharma generated promotional study data.

Start with the Number Needed to Treat, Absolute Risk Reduction. Look at adverse events and diabetes, Alzheimer's.

This will be a good start.

 

[anonymous]

I advise you to do your research on statins. They are not needed. Search for the real information, not the Pharma generated promotional study data.

Start with the Number Needed to Treat, Absolute Risk Reduction. Look at adverse events and diabetes, Alzheimer's.

This will be a good start.

Exactly… bempo isn’t a statin! It’s a setup that almost can’t be dreamed or imagined. To the moon!
Negative Nellie is left in the dust, outside trying to look in. Sad.

 

[anonymous]

Exactly… bempo isn’t a statin! It’s a setup that almost can’t be dreamed or imagined. To the moon!
Negative Nellie is left in the dust, outside trying to look in. Sad.

Dumpo bempo.

Not needed.

What is the Number Needed to Treat and Time to treat, to prevent 1 event?

Bet I don't get an answer here. No Clinical discussion from the Scientifically Hired Elites.

 

[anonymous]

Dumpo bempo.

Not needed.

What is the Number Needed to Treat and Time to treat, to prevent 1 event?

Bet I don't get an answer here. No Clinical discussion from the Scientifically Hired Elites.

Answer finance and BD questions that you avoided first, bitch.

 

[anonymous]

Answer finance and BD questions that you avoided first, bitch.

The stock price says it all. Bempo not needed.

 

[anonymous]

The stock price says it all. Bempo not needed.

No Finance and BD discussion from the cackling bitch Karen

 

[anonymous]

The stock price says it all. Bempo not needed.

Oh shut up! your a little pip squeak, goof who is a nothing surfing our site.. Why?

You’re nothing but a COTTON-HEADED NINNY MUGGIN! Bahahah

 

[anonymous]

More insults from the Ann Arbor crowd. We confronted for a clinical discussion the insults start. This drug is nothing more than a fart in a windstorm. Look at the stock depletion of 97% in last 4 years. That's a massacre!!

 

[anonymous]

OK, so sales have fallen a little short of expectations up to this point. The fact of the matter is that we now have outcomes data and a tremendous amount of acceleration behind our sales momentum . NASCAR doesn’t lie, we know our assets can swing in the marketplace. EZ pickings lie ahead.

 

[anonymous]

Yep nothing like a dipshit NASCAR fan. Likely never graduated high school and dipping chewing tobacco. In fact it probably helps lower LDL!! Stop the stupid posts about how great Esperion is. It's a third rate company with a second rate drug. The market responded accordingly to your precious Outcomes Data. Why else would DS withhold payment and in typical Esperion fashion they sue over their crappy data. What a tent in the woods outfit!!

 

[anonymous]

Yep nothing like a dipshit NASCAR fan. Likely never graduated high school and dipping chewing tobacco. In fact it probably helps lower LDL!! Stop the stupid posts about how great Esperion is. It's a third rate company with a second rate drug. The market responded accordingly to your precious Outcomes Data. Why else would DS withhold payment and in typical Esperion fashion they sue over their crappy data. What a tent in the woods outfit!!

Bitch Karen still cackling